Second source lateral flow manufacturing
Aiding supply and demand in potential disruptive periods such as the current COVID-19 outbreak. Read More
Aiding supply and demand in potential disruptive periods such as the current COVID-19 outbreak. Read More
Learn about the key changes to the In Vitro Diagnostic Directive and the areas you should be actively considering. Read More
Learn about some of the technical considerations for selecting antibodies during lateral flow assay development. Read More
Nina Garrett, Head of Assay Development, looks at the technical considerations when starting a lateral flow project. Read More
mHealth Software Regulation: part II: Regulations for mHealth in the USA, the largest diagnostic market. Read More
mHealth Software Regulation: part I: European regulation surrounding the rapid growing mHealth market. Read More
"Early adopters such as triathletes are at the pointy end of this drive towards consumer health diagnostics." Read More
A few considerations to think about when wanting to maximise profit for your lateral flow rapid test. Read More
What barriers can be broken down to aid recruitment and retention of clinical trial volunteers? Read More
Octylphenol ethoxylates are now included in the Annex XIV of REACH. What does it mean for LFIAs that use OPEs? Read More
See how rapid near-patient tests and data solutions can facilitate a patient centric approach to clinical trials. Read More
Switching lateral flow manufacturer doesn’t have to be a headache and could change the prospects of your business. Read More